Czechia, July 21 -- Czechia based PROMEDICA PRAHA GROUP, a.s. has secured contract from Revmatologicky ustav for Antineoplastic and immunomodulating agents - Drug deliveries - Adalimumab 2026 . The value of the contract is worth 48704000 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....